Clinical Trial Update: A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study [NA]

View source ↗

Summary

This entry reports the NO-ALS extension study evaluating a nicotinamide/pterostilbene supplement for amyotrophic lateral sclerosis; the trial is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Nicotinamide (nicotinamide)
• Pterostilbene (pterostilbene)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: RECRUITING